Douglass Winthrop Advisors’s Sanofi SNY Stock Holding History

Douglass Winthrop Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-13,520	Closed	-$648K	–	255
2017 Q2	$648K	Buy	13,520 +6,200	+85%	+$296K	0.04%	150
2017 Q1	$331K	Sell	7,320 -6,800	-48%	-$288K	0.02%	195
2016 Q4	$571K	Sell	14,120 -4,200	-23%	-$165K	0.04%	147
2016 Q3	$700K	Buy	18,320 +8,300	+83%	+$333K	0.05%	136
2016 Q2	$419K	Sell	10,020 -5,000	-33%	-$205K	0.03%	167
2016 Q1	$603K	Sell	15,020 -4,260	-22%	-$171K	0.04%	148
2015 Q4	$822K	Sell	19,280 -3,580	-16%	-$165K	0.06%	133
2015 Q3	$1.08M	Buy	22,860 +8,660	+61%	+$441K	0.09%	116
2015 Q2	$702K	Hold	14,200	–	–	0.05%	148
2015 Q1	$702K	Buy	+14,200	New	+$679K	0.05%	148

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Douglass Winthrop Advisors's SNY Position: Q3 2017 in Review

Douglass Winthrop Advisors sold out of Sanofi (SNY) in Q3 2017, closing a stake of 13,520 shares — an estimated $648K sold.

Douglass Winthrop Advisors first reported a position in SNY in Q1 2015 and held it in 10 quarters. The position peaked at $1.08M in Q3 2015. 485 funds tracked by Wall St. Rank hold SNY as of Q3 2017.

Douglass Winthrop Advisors reported no remaining Sanofi position as of Q3 2017 after selling out during the quarter.
Douglass Winthrop Advisors sold 13,520 Sanofi shares in Q3 2017, an estimated $648K.
Douglass Winthrop Advisors first reported a position in Sanofi in Q1 2015 and held it in 10 quarters.
Douglass Winthrop Advisors's Sanofi position peaked at $1.08M in Q3 2015.
485 funds tracked by Wall St. Rank held Sanofi as of Q3 2017.

Based on Douglass Winthrop Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.